Alternately, studies have reported infiltrating NK cells in the cervix with the CD56brightCD16- phenotype, which could respond to the positive regulation of the CD155 ligand DNAM-1 and the MICA ligand of NKG2D that have been reported in cervical cancer biopsies. The gene discussed is KLRK1; the disease is cervical carcinoma.